S.Korea says Novavax, Sputnik V COVID-19 vaccines submitted for regulatory approval

  • 3 years   ago
S.Korea says Novavax, Sputnik V COVID-19 vaccines submitted for regulatory approval

South Korea's drug safety ministry said on Thursday that Russia's Sputnik V coronavirus vaccine and a shot developed by Novavax (NVAX.O) have been submitted for preliminary regulatory approval.

 

 

REUTERS

Comments